Pro Medicus, AU000000PME8

Pro Medicus stock wins AUD 128 million NYC hospital contract

Published on 11/20/2026 at 20:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Pro Medicus stock adds a 10-year AUD 128 million NYC Health + Hospitals contract. The cloud rollout is targeted for late Q3 2027.

Contract expands US platform reach

  • Visage Imaging will deploy the cloud-based Visage 7 platform across NYC Health + Hospitals.
  • The transaction-based agreement includes Viewer, Workflow and Open Archive, with go-live targeted for late in the third quarter of calendar 2027.
  • Pro Medicus expects the contract to support its US healthcare imaging expansion.
Pro Medicus, AU000000PME8, Illustration mit AI erstellt.

Pro Medicus announced on Friday, November 20, that its wholly owned US subsidiary Visage Imaging had signed a 10-year contract worth AUD 128 million with NYC Health + Hospitals. Rask Media reported that the agreement covers the healthcare system's cloud-based imaging deployment.

Under the contract, Visage 7 Viewer, Visage 7 Workflow and Visage 7 Open Archive will be implemented across NYC Health + Hospitals. The platform will provide a unified diagnostic imaging system, migrate legacy PACS archives to Open Archive and integrate image distribution with the customer's electronic health record.

Cloud rollout sets 2027 milestone

Planning is scheduled to begin immediately, with go-live targeted for late in the third quarter of calendar 2027. The agreement uses a transaction-based licensing model, which gives Pro Medicus potential revenue upside if imaging volumes exceed the contracted assumptions.

NYC Health + Hospitals is the largest municipal healthcare delivery system in the United States, according to Rask Media. The contract broadens Pro Medicus' exposure to a large public healthcare network while extending the company's cloud implementation pipeline.

Evening quote in euros

Pro Medicus stock traded at 111.43 euros on Lang & Schwarz at 20:34 CET on Friday, November 20, 2026.

Pro Medicus Limited

  • Company: Pro Medicus Limited
  • ISIN: AU000000PME8
  • ASX ticker: PME
  • Home exchange: Australian Securities Exchange
  • Lang & Schwarz quote: 111.43 euros at 20:34 CET on November 20, 2026

Australian equities are tracked through the S&P/ASX 200 market environment.

More news and analyses on Pro Medicus stock

Disclaimer...
en | AU000000PME8 | PRO MEDICUS | boerse | 70541058 | bgmi